Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 11/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10099509 | 0.81 | HPGD (0.41) | ALDH1A1HSD17B10TDP1MAPK1ALOX15 | |
| SCHEMBL14259347 | 0.77 | NSD2 (0.53) | ALDH1A1HSD17B10ALOX12TSHRL3MBTL1 | |
| SCHEMBL13707227 | 0.77 | NSD2 (0.44) | ALDH1A1HSD17B10ALOX12TSHRL3MBTL1 | |
| SCHEMBL13046151 | 0.77 | ALDH1A1 (0.38) | ALDH1A1HSD17B10ALOX12TSHRL3MBTL1 | |
| SCHEMBL13295121 | 0.76 | ALDH1A1 (0.42) | ALDH1A1HSD17B10TSHRALOX15MAPT | |
| SCHEMBL13084292 | 0.76 | IDO1 (0.36) | TDP1PTGS2CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL12429486 | 0.74 | CDC25B (0.51) | ALDH1A1HSD17B10TSHRTDP1ALOX15 | |
| SCHEMBL11328192 | 0.72 | ALDH1A1 (0.68) | ALDH1A1HSD17B10ALOX12TSHRL3MBTL1 | |
| SCHEMBL13308528 | 0.72 | ALDH1A1 (0.68) | ALDH1A1HSD17B10ALOX12TSHRL3MBTL1 | |
| SCHEMBL11961732 | 0.72 | ALDH1A1 (0.68) | ALDH1A1HSD17B10ALOX12TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9551928-B2 | Actinic-ray- or radiation-sensitive resin composition and method of forming pattern therewith | FUJIFILM CORPORATION (JP) | 2017-01-24 | — | — | US | disclosed |
| US-20100255418-A1 | ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN THEREWITH | FUJIFILM CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| US-7709547-B2 | Ink composition, inkjet recording method, printed material, production method of a planographic printing plate and planographic printing plate | FUJIFILM CORPORATION (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20070115326-A1 | Ink composition, inkjet recording method, printed material, production method of a planographic printing plate and planographic printing plate | FUJIFILM CORPORATION | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100255418-A1 | ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN THEREWITH | RER1, NOC2L, RAD51 | ALDH1A1 2338/4885HSD17B10 4783/4885ALOX12 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.